Cinemark CMO’s 10b5-1 sale: 1,254 shares at $28.49 each

Rhea-AI Filing Summary

Form 4 filing for Cinemark Holdings (CNK) discloses that Chief Marketing & Content Officer Wanda Marie Gierhart sold 1,254 common shares on 1 Aug 2025 at $28.49 per share, a transaction value of roughly $35.7 k. The sale was executed automatically under a Rule 10b5-1 plan adopted 13 Mar 2025, limiting discretionary timing. After the trade, Gierhart still owns 92,754 shares, so only ~1.3 % of her holdings were liquidated. No derivative securities were involved.

The modest size relative to her remaining stake and the use of a pre-set trading plan suggest limited informational signal for investors. The filing does not indicate any change in role or additional corporate events.

Positive

• Sale executed under Rule 10b5-1 plan, reducing potential signaling risk and indicating a scheduled, nondiscretionary transaction.
• Officer retains 92,754 shares, demonstrating continued alignment with shareholder interests.

Negative

• Insider selling activity, even if small, can be perceived negatively by some investors.

Insights

Securities Analyst

TL;DR: Small 10b5-1 sale; negligible impact on CNK valuation.

The transaction represents about 1 % of the officer’s ownership and <0.1 % of CNK’s daily volume. Because it occurred under a pre-arranged 10b5-1 plan, information asymmetry risk is muted. Insider still retains a sizable position, signalling continuing alignment with shareholders. Given the scale, I classify the event as routine and unlikely to influence price discovery or analyst models.

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

X

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Gierhart Wanda Marie

(Last) (First) (Middle)

3900 DALLAS PARKWAY

(Street)

PLANO TX 75093

(City) (State) (Zip)

2. Issuer Name and Ticker or Trading Symbol
Cinemark Holdings, Inc. [ CNK ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

	Director		10% Owner
X	Officer (give title below)		Other (specify below)
	Chief Marketing & Content Ofc

3. Date of Earliest Transaction (Month/Day/Year)
08/01/2025

4. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common Stock	08/01/2025		D		1,254(1)	D	$28.49	92,754	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

1. The sale reported on this Form 4 occured automatically pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on March 13, 2025.

	/s/ Michael Cavalier attorney-in-fact	08/05/2025
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

FAQ

How many CNK shares did Wanda Gierhart sell on 08/01/2025?

1,254 common shares were sold.

At what price were the Cinemark shares sold?

The shares were disposed at $28.49 each.

How many CNK shares does the officer own after the sale?

Gierhart holds 92,754 shares following the transaction.

Was the sale part of a 10b5-1 trading plan?

Yes, the sale was automatically executed under a 10b5-1 plan adopted on 03/13/2025.

Does the filing mention any derivative transactions?

No, no derivative securities were acquired or disposed of.